Strong interest in WorkBeads™ affimAb Edge: Next-Generation Protein A Resin for Antibody Purification

Bio-Works Technologies AB announced on August 19th, 2025, the launch of  WorkBeads™ affimAb Edge, a resin with market leading performance designed for efficient purification of monoclonal antibodies and Fc-containing fragments or fusion proteins from laboratory to production scale.
Built on an improved macroporous agarose-based matrix and coupled with an alkali-stable recombinant Protein A ligand, WorkBeads affimAb Edge delivers:

· High performance and process economy: Dynamic binding capacities exceeding 70 mg/mL at 6 minutes residence time.
· Superior pressure flow properties: